contact us
BARDA is pouring $454 million more into Johnson & Johnson’s Covid-19 vaccine efforts, as the pharma huffs and puffs to catch up with fast-moving frontrunners Pfizer/BioNTech and Moderna.
Do Not Allow Advertisers to Use My Personal information
